Inhibition of CD38 With the Thiazoloquin(az)olin(on)e 78c Protects the Heart Against Post-Ischemic Injury
Journal of Pharmacology and Experimental Therapeutics - United States
doi 10.1124/jpet.118.254557
Full Text
Open PDFAbstract
Available in full text
Date
January 11, 2019
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)